Companies / Halozyme Therapeutics Inc

Halozyme Therapeutics Inc

Nasdaq: HALOCIK 1159036SAN DIEGO, CAhalozyme.com ↗
Insider flow · last 90 daysNet sells $4.03M

Financials · FY2025

Revenue$1.40B
Net income$316.89M
Total debt$1.94B
Cash$163.14M
Diluted EPS$2.56
Shares outstanding113.5M

Ownership

113.5M shares outstanding · as of Jul 31, 2026
0.94%Insiders
Ownership
Insiders0.94%1,064,196
10%+ / strategic5.44%6,173,547
Institutions109.88%124,711,619
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 12

View all →
Insider% of sharesShares
Torley HelenCEOPRESIDENT AND CEO · Director
0.68%767,780
Posard Matthew L.Director
0.07%77,835
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
0.04%49,929
Connaughton BernadetteDirector
0.04%43,669
LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICER
0.03%38,494
Henderson Jeffrey WilliamDirector
0.03%36,572
Duncan Barbara GayleDirector
0.02%23,715
Krishnan MaheshDirector
0.01%14,462
Caudill CortneySVP, CHIEF OPERATING OFFICER
<0.01%7,055
Lang James PaulDirector
<0.01%4,685

Institutional holders 625

View all →
HolderValue% of shares
BlackRock, Inc.$1.04B11.69%
Vanguard Group Inc$778.45M10.19%
State Street Corporation$405.38M4.56%
Invesco Ltd.$245.51M3.21%
Bank of America Corp /De$183.99M2.41%
Morgan Stanley$178.90M2.34%
Boston Partners$173.43M2.36%
Geode Capital Management, LLC$161.98M2.21%
Snyder Capital Management L P$150.14M2.05%
Dimensional Fund Advisors LP$141.61M1.85%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 16, 2026Torley Helen
CEO
OtherCommon Stock$2.19M-28K
-3.55%
749,731
0.66% of shares
low
Apr 1, 2026Torley Helen
CEO
SellCommon Stock$1.24M-19K
-2.41%
768,780
0.68% of shares
medium
Mar 9, 2026Caudill Cortney
Executive
SellCommon Stock$1.21M-18K
-52.09%
16,466
0.01% of shares
medium
Jun 2, 2026Torley Helen
CEO
SellCommon Stock$1.10M-17K
-2.11%
771,180
0.68% of shares
medium
Mar 2, 2026Torley Helen
CEO
SellCommon Stock$1.07M-15K
-1.96%
768,358
0.68% of shares
medium
Apr 2, 2026Torley Helen
CEO
SellCommon Stock$1.01M-16K
-2.01%
771,980
0.68% of shares
medium
Mar 3, 2026Torley Helen
CEO
SellCommon Stock$928.2K-13K
-1.71%
774,299
0.68% of shares
medium
Feb 16, 2026Torley Helen
CEO
OtherCommon Stock$900.4K-11K
-1.55%
718,394
0.63% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Vanguard Capital ManagementPassive13G—6,173,547—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
HALO——40637H109—